According to Federal State Statistics Service, Rosstat, in August, medicines related to vital and essential medicines became more expensive on average by 0.8%. Prices for non-vital and essential drugs increased by 0.9% on average.
The price has increased for the following drugs:
acetylsalicylic acid (domestic aspirin) – 5.6%,
pancreatin – 1.8%,
furosemide – 1.7%,
xarelto, ingavirin, drotaverine (no-spa) – 1.4%,
vinpocetine, aminophylline – 1.3%,
ibuprofen, omeprazole – 0.9%,
afobazole – 3.3%,
ketorol express – 2.5%,
allohol – 2.3%,
troxerutin – 2.1%,
activated carbon – 1.9%,
levomekol and magne B6 – 1.5%,
metamizole sodium (domestic analgin) – 1.4%,
methyluracil – 1.3%,
Canephron N – 1.2%,
fluocinolone acetonide – 1.1%,
nimesulide, sulfacetamide, corvalol, citramon – 1.0%.
Prices have decreased by:
phosphogliv – 0.7%,
ambroxol, colecalciferol (vitamin D3) – 0.3%,
enalapril, oseltamivir (Nomides) – 0.2%,
smecta – 0.1%,
sinupret – 2.5%,
iodine – 0.3%,
validol – 0.2%,
naphazoline – 0.1%.
